In metabolic diseases, however, higher levels of complexity exist due to diverse factors that contribute to the pathophysiology, as well as the participation of various metabolic tissues, including adipose tissue and liver, which makes generalizable conclusions difficult with regard to how irisin/FNDC5 is regulated. The gene discussed is FNDC5; the disease is metabolic disease.